Month: April 2026
U.S. and Iran haven’t backed ceasefire idea as Trump’s Hormuz Strait deadline nears
US President Donald Trump disembarks from Air Force One upon arrival at Joint Base Andrews in Maryland, March 23, 2026. Saul Loeb | Afp | Getty Images President Donald Trump has not backed an idea for a 45-day ceasefire that would take effect before his upcoming deadline for Iran to either reopen the Strait of […]
Read More
Microsoft is the worst performing Mag 7 stock this year. Goldman believes that’s about to change
Microsoft could gain ground as artificial intelligence seems poised to boost, rather than batter, shares of the “Magnificent Seven” stock, according to Goldman Sachs. The investment bank has a buy rating on Microsoft, with a $600 price target on shares, implying nearly 61% upside from Thursday’s close. “We believe the pace of deceleration in [Microsoft […]
Read More
S&P 500 rises as investors await possible Iran and U.S. ceasefire: Live updates
Traders work on the floor of the New York Stock Exchange (NYSE) at the opening bell in New York on April 2, 2026. Charly Triballeau | Afp | Getty Images The S&P 500 rose on Monday following a winning week as oil prices pulled back, with traders weighing the odds that the U.S.-Iran war could […]
Read More
China’s Xi urges faster development of new energy system as Middle East war continues
Chinese President Xi Jinping attends a meeting with Russian President Vladimir Putin and Mongolian President Ukhnaagiin Khurelsukh in Beijing, China Sept. 2, 2025. Sergey Bobylev | Via Reuters Chinese President Xi Jinping has called for accelerated planning and construction of a new energy system to safeguard the country’s energy security, weeks into the Iran war […]
Read More
Stocks making the biggest moves premarket: Netflix, Soleno Therapeutics, Strategy & more
Check out the companies making the biggest moves premarket: Netflix — The streaming platform climbed 1.5% after a Goldman Sachs upgrade to buy from neutral. The bank said it sees Netflix as continuing to be the leader in content acquisition and development, and a high chance for multiyear capital return back to shareholders. Soleno Therapeutics […]
Read More
Jet fuel costs weigh on airlines: Heres’s the impact on travel
CNBC’s Phil LeBeau joins ‘Squawk Box’ with the latest news. Source
Read More
Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout
Piotr Swiat | Lightrocket | Getty Images Neurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, marking the neuroscience-focused drugmaker’s expansion into metabolic disorders. The deal gives Neurocrine access to Vykat XR, the first drug approved in the U.S. to treat hyperphagia associated with Prader-Willi syndrome, […]
Read More
Hope for a U.S.-Iran deal, Apple’s anniversary, OpenAI’s podcast deal and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Monday. My alma mater is in tonight’s March Madness championship game. While I’m not a big sports person, I have too many friends whose brackets depend on this game to not mention the Wolverines. S&P 500 futures are higher this morning […]
Read More
JPMorgan CEO Jamie Dimon in annual letter cites risks in geopolitics, AI and private markets
Jamie Dimon, Chairman and CEO, JPMorganChase, speaks during the Reagan National Defense Forum at the Ronald Reagan Presidential Library in Simi Valley, California, U.S. December 6, 2025. Jonathan Alcorn | Reuters JPMorgan Chase CEO Jamie Dimon is calling for a broad recommitment to American ideals as his bank navigates geopolitical uncertainty, a teetering economy and […]
Read More